All News
Integra LifeSciences Reports First Quarter 2024 Financial Results
Advancing Leaders Through Innovation
46 Years of Creating Magnificent Instruments
Daniel Ray, team manager at our Saint-Aubin, France manufacturing site has built a lifetime of memories working with his hands.
Integra LifeSciences Completes The Acquisition Of Acclarent, Inc.
Integra today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent's innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel.
Healthcare Businesswomen’s Association Recognizes Topaz Kirlew During Women’s History Month
Congratulations to Topaz Kirlew, vice president, Regulatory Affairs, a 2024 Healthcare Businesswomen’s Association (HBA) Luminary! Topaz received this honor for Accelerating Transformational Leadership and driving significant positive change.
Soaring to New Heights
Integra LifeSciences Launches MicroMatrix® Flex To Provide Convenient Access To Hard-To-Reach Areas In Complex Cases
Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology
Integra LifeSciences Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides 2024 Financial Guidance
Integra LifeSciences reported financial results for the fourth quarter and full year 2023.
Finding Her Passion and Purpose
Starr Bland, associate product manager, shares her journey of determination and focus in pursuit of her career aspirations, while building a community along the way.
Integra Named one of Top 25 Medical Device Companies for 2024
Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent®
PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company for $275 million in cash at closing, subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones. Acclarent is an innovator and market leader in ENT procedures and upon closing, Integra will be one of the leading providers of ENT products and technologies.
Le Locle Quality Assurance Analyst Karin Balanche Says Quality is Collaborative
Karin Balanche, quality assurance analyst at Integra’s Le Locle, Switzerland manufacturing facility, has been with the company for more than six years. She remains just as passionate and energized about her work since her first day because of the collaboration of her team and impact of Integra’s technologies on patients. She oversees customer satisfaction, with elements of compliance and regulatory affairs for products like shunts, valves, and catheters for neurosurgery.